Furthermore, ANCR, the long non-coding RNA (lncRNA), can promote the CDK1–EZH2 interaction, resulting in EZH2 ubiquitination and its degradation in breast cancer cells in vitro. The gene discussed is EZH2; the disease is breast carcinoma.